Effective LMA insertion: Lidocaine and propofol comparison with propofol alone

Main Article Content

Patchamon Sathonsaowapak
Samanan Lertkamolman

Abstract

          Propofol is the induction agent used to facilitate the placement of LMA without muscle relaxant. It depressed airway reflexes effectively. We used the efficacy of lidocaine to improve LMA insertion conditions. A propofol dose ranging from 2.5 to 3 mg/kg is recommended for LMA insertion. Among the propofol minimum dose 2.5 mg/kg alone, propofol dose 2 mg/kg and lidocaine iv. and topical lidocaine, which  methods had the best effectiveness and lowest the complications. Methods: This was a prospective double blind control study. We enrolled patients aged 18-65 year undergoing elective surgery, ASA status I-II and anesthesiologist chose the laryngeal mask airway for them. Patients were divided into 3 groups of 50 in each. Group P received propofol 2.5 mg/kg, Group TL-P received 40 mg of topical lidocaine over posterior pharyngeal wall followed 3 min later by propofol 2 mg/kg, and Group IV-P received intravenous lidocaine 1.5 mg/kg 3 min before propofol 2 m g/kg. Jaw opening, coughing, gagging, body movement, laryngospasm and apnea time were recorded. Results: Incidence of gagging, body movement (insertion and after insertion) were found mainly in Group IVL-P (P value < 0.05) and the frequency of optimal insertion condition was lower in Group IVL-P (P value = 0.018).  Conclusions: Topical lidocaine 40 mg followed by propofol 2 mg//kg was effective equally to propofol 2.5 mg/kg for insertion of LMA with the in different complications.  

Article Details

How to Cite
Sathonsaowapak, P. ., & Lertkamolman, S. . (2024). Effective LMA insertion: Lidocaine and propofol comparison with propofol alone. Maharat Nakhon Ratchasima Hospital Journal, 38(1), 17–24. Retrieved from https://he04.tci-thaijo.org/index.php/MNRHJ/article/view/1565
Section
Original Article

References

Stoneham MD. Facilitation of laryngeal mask insertion. Effects of lignocaine given intravenously before induction with propofol. Anesthesia 1995; 50: 464-6.

Cook TM. Lignocine to aid the insertion of the laryngeal mask airway with thiopentone. A comparison between topical and intravenous administration. Anesthesia 1996; 51: 787-90.

Seavell CR. Topical lignocaine and thiopentone for the insertion of a laryngeal mask airway. A comparison with propofol. Anesthesia 1996; 51: 699-701.

Changchien CF. Topical lidocaine improves conditions for laryngeal mask airway insertion. Can J Anesth 2010; 57: 446-52.

Gharaei B, Jafari A. Topical versus intravenous lidocaine in children with upper respiratory infection undergoing anesthesia: A randomized, double blind, clinical trial. Anesth Pain Med 2015; 5(4): e23501.

Erb TO, von Ungern-Sternberg BS. The effect of intravenous lidocaine on Laryngeal and respiratory reflex responses in anaesthetized children. Anaesthesia 2013; 68: 13-20.

Asai T, Morris S. The laryngeal mask airway: its features, effects and role. Can J Anesth 1994; 41:930-60.

Staikou C, Paraskeva A. Intravenous lidocaine does not affect the anesthetic depth during rapid sequence induction and intubation as assessed by Bispectral Index monitoring : a randomized double blind study. Arch Med Sc 2013; 9: 713-8.

Yukioka H, Yoshimoto N. Intravenous lidocaine as a suppressant of coughing during tracheal intubation. Anesthesia Analgesia 1985; 64: 1189-92.

Goh PK, Chiu CL. Randomized double-blind comparison of ketamine-propofol, fentanyl-propofol and propofolsaline on haemodynamics and laryngeal mask airway insertion conditions. Anaesth Intensive Care 2005; 33: 223-8.